Travere Therapeutics grants inducement equity awards for 41,600 shares to six new employees
TVTX•Inducement equity awards for new hires
Travere Therapeutics granted inducement equity awards covering 41,600 shares to six new employees on July 10, 2026.
The package includes stock options for 18,000 shares priced at $56.59, with a 10-year term.
The options vest over four years: 25% after one year, with the remainder vesting monthly over the next 36 months.
Restricted stock units cover 23,600 shares, vesting 25% on each anniversary over four years.
